Precision BioSciences, Inc. · SWB:PBS0

Precision BioSciences, Inc. financial statements

Precision BioSciences, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue34.3M68.7M48.7M25.1M115.5M24.3M1.07B10.9M6.48M7.01M
Cost of revenue2.75M4.58M8.26M9.00M000
Gross profit34.3M68.7M48.7M25.1M115.5M24.3M22.2M10.9M6.48M7.01M
Research and development54.2M59.6M53.4M46.1M115.2M98.1M82.4M45.1M20.3M9.10M
Selling, general and administrative32.2M35.3M39.1M41.3M39.7M36.1M27.0M13.7M8.02M6.17M
Operating income-52.1M-26.2M-43.7M-62.3M-39.4M-109.8M-87.2M-47.9M-22.0M-8.83M
Depreciation and amortization1.47M3.40M6.82M7.80M8.98M8.78M5.32M2.35M1.44M640.0K
EBITDA-50.7M-22.8M-36.9M-54.5M-30.4M-101.1M-81.9M-45.6M-20.5M-8.19M
Interest expense1.42M1.78M2.23M1.11M132.0K822.0K182.0K000
Income before tax-45.7M7.17M-42.5M-72.9M-30.6M-109.0M-92.9M-46.0M-21.1M-8.26M
Income tax0027.2M11.3M316.0K23.0K-9.58M1.88M-754.0K-5.00K
Net income-45.7M7.17M-61.3M-111.6M-30.6M-109.0M-92.9M-46.0M-21.1M-8.25M
Earnings per share, basic-3.561.05-15.96-38.10-0.52-2.09-2.21-2.92-18.81-0.49
Earnings per share, diluted-3.561.04-15.96-38.10-0.52-2.09-2.21-2.92

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents110.8M85.9M116.7M189.6M143.7M89.8M180.9M103.2M62.8M93.4M
Short-term investments4.76M413.0K0
Receivables0229.0K901.0K720.0K488.0K10.0M965.0K523.0K22.0K386.0K
Inventory7.55M17.4M5.76M9.50M
Current assets118.7M95.0M136.4M199.1M161.8M105.6M193.7M115.7M64.3M94.4M
Property, plant and equipment1.43M3.09M6.34M11.8M25.2M35.1M39.6M21.1M8.14M3.54M
Total assets154.4M136.4M159.8M238.2M211.5M150.2M235.2M138.6M72.7M98.4M
Accounts payable296.0K1.31M2.97M653.0K1.14M792.0K2.04M2.22M1.81M1.29M
Current liabilities8.91M15.0M50.0M59.7M36.0M42.8M26.9M14.1M9.20M8.34M
Long-term debt22.4M22.3M22.2M2.48M
Total debt28.8M30.0M31.3M22.2M2.48M10.5M
Total liabilities62.2M80.0M140.9M177.7M120.3M105.7M96.9M98.6M99.1M103.2M
Shareholders' equity92.2M56.4M18.9M60.4M91.2M44.4M138.3M40.0M-26.4M-4.75M
Shares outstanding24.1M8.20M4.16M3.70M60.9M52.7M51.2M15.9M1.12M16.7M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations-65.8M-58.4M-84.1M-45.8M-10.9M-87.4M-71.0M-51.7M-24.2M92.3M
Capital spending-85.0K-250.0K-1.96M-3.32M-5.05M-5.03M-24.7M-14.3M-5.57M-2.08M
Free cash flow-65.9M-58.7M-86.1M-49.1M-15.9M-92.4M-95.7M-66.0M-29.7M90.2M
Cash from investing-634.0K-215.0K5.83M-3.32M-5.80M-5.03M-24.7M-15.7M-5.51M-2.08M
Cash from financing95.2M50.5M5.39M95.0M70.5M1.33M173.4M107.8M-937.0K-12.4M
Dividends paid-12.4M
Share buybacks74.7M67.3M689.0K136.4M0-952.0K49.0K
Change in cash28.7M-8.21M-72.9M45.9M53.9M-91.1M77.7M40.4M-30.6M77.8M